Condition
Intracranial Neoplasms
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Withdrawn2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT02563288Phase 3Unknown
Esmolol Versus Dexmedetomidine During Intracranial Procedures
NCT02478346Phase 4Unknown
Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions
NCT01445691Phase 2Withdrawn
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
NCT00247403Phase 1WithdrawnPrimary
Safety Study of 2DG With Stereotactic Radiosurgery
Showing all 4 trials